What’s in a name?
Pharma companies take advantage of legal loopholes to market different formulations under same or similar brand names, says Sapna Dogra.

Not yet for the masses
It may be a more than million-dollar market, but the Indian players don’t seem too keen on pushing for a switch from prescription to OTC drugs says Deepali Gupta.